GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » Cyclically Adjusted Book per Share

Cassava Sciences (MEX:SAVA) Cyclically Adjusted Book per Share : MXN146.25 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cassava Sciences's adjusted book value per share for the three months ended in Mar. 2025 was MXN54.045. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN146.25 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Cassava Sciences's average Cyclically Adjusted Book Growth Rate was -9.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -2.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -4.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cassava Sciences was 2.40% per year. The lowest was -23.20% per year. And the median was -7.80% per year.

As of today (2025-05-29), Cassava Sciences's current stock price is MXN37.00. Cassava Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was MXN146.25. Cassava Sciences's Cyclically Adjusted PB Ratio of today is 0.25.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cassava Sciences was 9.90. The lowest was 0.07. And the median was 0.97.


Cassava Sciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Cassava Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences Cyclically Adjusted Book per Share Chart

Cassava Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 87.96 90.92 104.98 98.00

Cassava Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.14 119.92 79.27 98.00 146.25

Competitive Comparison of Cassava Sciences's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Cassava Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cassava Sciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cassava Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cassava Sciences's Cyclically Adjusted PB Ratio falls into.


;
;

Cassava Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cassava Sciences's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=54.045/134.9266*134.9266
=54.045

Current CPI (Mar. 2025) = 134.9266.

Cassava Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201506 86.271 100.684 115.612
201509 85.477 100.392 114.881
201512 77.247 99.792 104.444
201603 66.575 100.470 89.407
201606 64.489 101.688 85.568
201609 59.588 101.861 78.931
201612 58.289 101.863 77.209
201703 47.761 102.862 62.649
201706 36.366 103.349 47.477
201709 31.275 104.136 40.522
201712 28.879 104.011 37.463
201803 27.135 105.290 34.773
201806 24.351 106.317 30.904
201809 21.698 106.507 27.488
201812 22.382 105.998 28.490
201903 20.901 107.251 26.295
201906 19.883 108.070 24.824
201909 20.001 108.329 24.912
201912 19.082 108.420 23.747
202003 23.545 108.902 29.172
202006 22.401 108.767 27.789
202009 20.704 109.815 25.438
202012 52.047 109.897 63.901
202103 143.661 111.754 173.449
202106 137.549 114.631 161.902
202109 137.483 115.734 160.282
202112 130.165 117.630 149.305
202203 117.928 121.301 131.175
202206 109.561 125.017 118.246
202209 99.781 125.227 107.510
202212 106.290 125.222 114.528
202303 88.079 127.348 93.321
202306 73.349 128.729 76.881
202309 64.133 129.860 66.635
202312 55.246 129.419 57.597
202403 30.161 131.776 30.882
202406 72.162 132.554 73.454
202409 68.392 133.029 69.368
202412 63.041 133.157 63.879
202503 54.045 134.927 54.045

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Cassava Sciences  (MEX:SAVA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cassava Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=37.00/146.25
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cassava Sciences was 9.90. The lowest was 0.07. And the median was 0.97.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cassava Sciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cassava Sciences Business Description

Industry
Traded in Other Exchanges
Address
6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Cassava Sciences Headlines

From GuruFocus